Stochastic Oscillator Analysis for PDL BioPharma, Inc. (NASDAQ:PDLI)

3d blue background with stock diagram

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of PDL BioPharma, Inc. (NASDAQ:PDLI) for the period of 9-Day stands at 48.81% while the stochastic %D for the same period stands at 48.18%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of PDL BioPharma, Inc. (NASDAQ:PDLI) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for PDL BioPharma, Inc. (NASDAQ:PDLI) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently PDL BioPharma, Inc. (NASDAQ:PDLI)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.

Previous Day Activity Analysis

On the last trading day, PDL BioPharma, Inc. (NASDAQ:PDLI) opened the session at $3.03 and after going up 0.66% closed at $3.06. The stock gained 0.03 points in the last trade.

PDL BioPharma, Inc. (NASDAQ:PDLI)’s stock fluctuated in the range of $2.98 and $3.07 during the previous active session. PDL BioPharma, Inc. (NASDAQ:PDLI) traded with the volume of 1.31 Million with average volume of 1.94 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 0.53 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.13 and 41.17 respectively.

Currently the Insider Ownership of the shares of PDL BioPharma, Inc. (NASDAQ:PDLI) is at 0.9% and the shares outstanding are 153.59 Million.

Important Ratio Analysis

Some important ratios to consider here for PDL BioPharma, Inc. (NASDAQ:PDLI) are discussed below:

Price to Earnings P/E ratio stands at 6.02 while Forward P/E shows the value of 7.46.

The PEG ratio (Price to Earning to Growth) emits the value of 0.43. The Price to Sale P/S and Price to Book P/B shows the value of 1.48 and 0.58 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 1.08 and 0 correspondingly.

The Quick Ratio of PDL BioPharma, Inc. (NASDAQ:PDLI) stands at 1.9 while the Current Ratio depicts the value of 1.9.

Return on Assets ROA of PDL BioPharma, Inc. (NASDAQ:PDLI) is at 1.2% whereas, Return on Equity ROE and Return of Investment ROI of PDL BioPharma, Inc. (NASDAQ:PDLI) stand at 1.9% and 8.3% respectively.

The payout ratio of PDL BioPharma, Inc. (NASDAQ:PDLI) stands at 54.7%.

Stock Performance Analysis

The stock performance of PDL BioPharma, Inc. (NASDAQ:PDLI) on the basis of 5 day trade show the dip of -0.65% whereas, the monthly performance of the stock shows decrease of -11.82%.

The quarterly performance of the stock remained in green zone with the value of 9.68% while six month performance of the shares of PDL BioPharma, Inc. (NASDAQ:PDLI) remained bullish with the count of 28.57%.

The yearly and YTD performance of PDL BioPharma, Inc. (NASDAQ:PDLI) remained mix at -14.53% and 44.34% respectively.